Under Senate Bill, Medicare Can Negotiate Some Drug Prices, But Power to Lower Prices Still Limited

When the Inflation Reduction Act passed the Senate Sunday, Republicans successfully blocked a price cap on insulin. Robert Weissman, president of Public Citizen, says that despite its flaws, the bill is a win against the pharmaceutical…